Camber Capital Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,650,000
| Closed | -$8.75M | – | 38 |
|
|
2024
Q1 | $8.75M | Sell |
1,650,000
-1,155,000
| -41% | -$6.12M | 0.21% | 32 |
|
|
2023
Q4 | $12.1M | Sell |
2,805,000
-1,430,000
| -34% | -$6.19M | 0.31% | 30 |
|
|
2023
Q3 | $11.1M | Hold |
4,235,000
| – | – | 0.37% | 34 |
|
|
2023
Q2 | $15M | Hold |
4,235,000
| – | – | 0.49% | 32 |
|
|
2023
Q1 | $13.1M | Hold |
4,235,000
| – | – | 0.4% | 33 |
|
|
2022
Q4 | $17.9M | Hold |
4,235,000
| – | – | 0.61% | 29 |
|
|
2022
Q3 | $10M | Hold |
4,235,000
| – | – | 0.31% | 42 |
|
|
2022
Q2 | $12.1M | Buy |
4,235,000
+235,000
| +6% | +$670K | 0.52% | 32 |
|
|
2022
Q1 | $11.5M | Buy |
4,000,000
+1,950,000
| +95% | +$5.62M | 0.42% | 32 |
|
|
2021
Q4 | $6.23M | Sell |
2,050,000
-1,375,000
| -40% | -$4.18M | 0.21% | 31 |
|
|
2021
Q3 | $24M | Buy |
3,425,000
+700,000
| +26% | +$4.91M | 0.74% | 28 |
|
|
2021
Q2 | $25M | Buy |
2,725,000
+170,000
| +7% | +$1.56M | 0.84% | 30 |
|
|
2021
Q1 | $24.8M | Hold |
2,555,000
| – | – | 0.85% | 28 |
|
|
2020
Q4 | $26.2M | Hold |
2,555,000
| – | – | 0.92% | 25 |
|
|
2020
Q3 | $25.8M | Buy |
2,555,000
+155,000
| +6% | +$1.56M | 1.36% | 23 |
|
|
2020
Q2 | $25M | Buy |
2,400,000
+450,000
| +23% | +$4.69M | 1.43% | 19 |
|
|
2020
Q1 | $16.5M | Buy |
+1,950,000
| New | +$16.5M | 0.98% | 24 |
|
|
2019
Q1 | – | Sell |
-1,300,000
| Closed | -$26.5M | – | 34 |
|
|
2018
Q4 | $26.5M | Buy |
1,300,000
+550,000
| +73% | +$11.2M | 1.26% | 25 |
|
|
2018
Q3 | $34.4M | Buy |
+750,000
| New | +$34.4M | 1.47% | 19 |
|
|
2017
Q2 | – | Sell |
-650,000
| Closed | -$24.2M | – | 35 |
|
|
2017
Q1 | $24.2M | Buy |
+650,000
| New | +$24.2M | 0.98% | 23 |
|